| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 740,5 k € | +32.0% | 560,8 k € | +11.3% | 503,9 k € | +16.3% | 433,2 k € | +15.1% | 376,3 k € | +17.3% | 320,9 k € | +4.0% | 308,6 k € | +77.0% | 174,4 k € | -2.8% | 179,4 k € | -12.1% | 204,1 k € | -17.1% | 246,3 k € | |
| EBITDA | 740,4 k € | +32.0% | 560,7 k € | +11.3% | 503,9 k € | +16.3% | 433,1 k € | +15.1% | 376,3 k € | +17.3% | 320,9 k € | +4.0% | 308,6 k € | +77.0% | 174,4 k € | -2.8% | 179,4 k € | -12.1% | 204,0 k € | -17.2% | 246,3 k € | |
| Operating profit | 714,5 k € | +32.0% | 541,4 k € | +13.5% | 477,0 k € | +17.0% | 407,8 k € | +15.4% | 353,5 k € | +20.3% | 293,8 k € | +9.5% | 268,4 k € | +108.0% | 129,0 k € | +2.8% | 125,5 k € | +21.2% | 103,5 k € | -55.4% | 232,3 k € | |
| Profit/loss | 532,6 k € | +31.6% | 404,6 k € | +13.1% | 357,7 k € | +16.9% | 306,0 k € | +14.4% | 267,5 k € | +26.9% | 210,8 k € | +9.6% | 192,3 k € | +146.9% | 77,9 k € | -2.9% | 80,2 k € | +18.4% | 67,7 k € | -54.9% | 150,2 k € | |
| Equity | 20,5 k € | -4.8% | 21,5 k € | +3.0% | 20,9 k € | -1.6% | 21,2 k € | -0.1% | 21,2 k € | -2.5% | 21,8 k € | +3.9% | 20,9 k € | +1.6% | 20,6 k € | -93.4% | 310,5 k € | +34.8% | 230,3 k € | +41.7% | 162,6 k € | |
| Total assets | 697,9 k € | +23.6% | 564,6 k € | +29.1% | 437,3 k € | +15.7% | 377,8 k € | +14.6% | 329,6 k € | -1.0% | 333,1 k € | -5.4% | 352,2 k € | +21.2% | 290,6 k € | -47.4% | 552,9 k € | +3.8% | 532,5 k € | +77.9% | 299,3 k € | |
| Cash | 619,2 k € | +35.4% | 457,3 k € | +10.0% | 415,7 k € | +23.0% | 337,9 k € | +24.6% | 271,1 k € | +5.9% | 256,1 k € | +2.9% | 248,9 k € | +50.7% | 165,1 k € | -56.9% | 383,4 k € | +21.6% | 315,4 k € | +26.1% | 250,1 k € | |
| Debts | 677,5 k € | +24.7% | 543,1 k € | +30.4% | 416,5 k € | +16.8% | 356,6 k € | +15.6% | 308,4 k € | +0.1% | 308,0 k € | -7.0% | 331,2 k € | +23.0% | 269,4 k € | +11.7% | 241,1 k € | -19.9% | 301,0 k € | +120.1% | 136,8 k € | |
Private company with limited liability · Wavre · incorporated on 17/07/2014
Private company with limited liability profitable but thinly capitalised. Cash position rising (+35.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (20,5 k €) relative to earnings. The abridged model hides revenue.
Dr. Lindita Mustaka, Ophtalmologie is a Private company with limited liability incorporated in 2014. Its main activity is: Specialist medical practice activities. Its registered office is in Wavre.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette